ArticleCurrent microbiology2024
Production and Evaluation of Ag85B:HspX:hFcγ1 Immunogenicity as an Fc Fusion Recombinant Multi-Stage Vaccine Candidate Against Mycobacterium tuberculosis.
Mohsen Karbalaei et al.PubMed ↗Publisher ↗
No numbers read from the abstract.